Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů

| 116.9 | C01CA24 | epinefrin | parent. | 0.5 | MG | 4,50 | O | | 00362 | ADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | | | | | 116.10 | C01CA14 | dopexamin | parent. | 500 | MG | 109,39 | H | | 117 | C01CE | léčiva ze skupiny inhibitorů fosfodiesterázy | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4146,65 | X | | 91980 | WINCORAM | inj 10x20ml 5mg/ml | SWI | F | | | | | 117.2 | C01CE02 | milrinon | parent. | 50 | MG | 3980,00 | X | | 118 | C01DA | vazodilatancia ze skupiny organických nitrátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 118.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5 | MG | 2,00 | | | | | | | | | | | | 118.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5 | MG | 3,00 | | | | | | | | | | | | 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,12 | | | 31089 | NITROMINT 2.6MG | tbl ret 60x2.6mg | EGI | H | | | | | 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 3,50 | | | 02405 | DINISAN RETARD 20MG | cps ret 30x20mg | ETS | F | | | | | 118.5 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 4,20 | | | 91591 | CARDIKET RETARD 120 | cps ret 20x120mg | SWP | D | | | | | 118.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60 | MG | 2,50 | | | 02379 | DINISAN RETARD 40MG | cps ret 30x40mg | ETS | F | | | | | 118.7 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 2,75 | | | 76402 | SORBIMON 20MG | tbl 100x20mg | MCK | D | | | | | 76401 | SORBIMON 20MG | tbl 50x20mg | MCK | D | | | | | 96190 | MONOSAN 20MG | tbl 30x20mg | PMP | CZ | | | | | 45821 | MONOSAN 20MG | tbl 500x20mg | PMP | CZ | | | | | 61467 | ISMN AL 20 | tbl 100x20mg | APA | D | | | | | 76400 | SORBIMON 20MG | tbl 20x20mg | MCK | D | | | | | 118.8 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60 | MG | 1,25 | | | | | | | | | | | | 118.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40 | MG | 2,49 | | | 76405 | SORBIMON 40MG | tbl 100x40mg | MCK | D | | | | | 76403 | SORBIMON 40MG | tbl 20x40mg | MCK | D | | | | | 76404 | SORBIMON 40MG | tbl 50x40mg | MCK | D | | | | | 61469 | ISMN AL 40 | tbl 100x40 mg | APA | D | | | | | 45822 | MONOSAN 40MG | tbl 500x40mg | PMP | CZ | | | | | 96191 | MONOSAN 40MG | tbl 30x40mg | PMP | CZ | | | | | 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 13,59 | H | | 04348 | NITRO-MACK | inj 10x5ml/5mg | MAC | D | | | | | 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 123,96 | H | | 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,59 | | | 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D | | | | | 31407 | NITROMINT | aer dos 1x10gm | EGY | H | | | | | 53139 | NITRILEX | aer 1x14gm/205davek | GNO | CZ | | | | | 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 8,80 | | | 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 121.1 | C01DA02 | glycerol trinitrát | sublng. | 2.5 | MG | 6,11 | | | 00231 | NITROGLYCERIN SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK | | | | | 121.2 | C01DA08 | isosorbid dinitrát | sublng. | 20 | MG | 3,03 | | | 122 | C01DX | ostatní vazodilatancia | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 122.1 | C01DX03 | oxifedrin | p.o. | 40 | MG | 4,79 | | | | | | | | | | | | 122.2 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6 | MG | 4,46 | | | 49557 | MOLSIHEXAL 2MG | tbl 60x2mg | SFS | D | | | | | 86441 | MOLSIHEXAL 2MG | tbl 60x2mg | HEX | D | | | | | 76154 | CORVATON | tbl 30x2mg | HBS | SK | | | | | 122.3 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6 | MG | 2,72 | | | 49552 | MOLSIHEXAL 4MG | tbl 30x4mg | SFS | D | | | | | 49558 | MOLSIHEXAL 4MG | tbl 60x4mg | SFS | D | | | | | 83474 | MOLSIHEXAL 4MG | tbl 30x4mg | HEX | D | | | | | 86442 | MOLSIHEXAL 4MG | tbl 60x4mg | HEX | D | | | | | 76155 | CORVATON FORTE | tbl 30x4mg | HBS | SK | | | | | 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 2,10 | | | 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | HEX | D | | | | | 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | HEX | D | | | | | 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | HEX | D | | | | | 86443 | MOLSIHEXAL RETARD | tbl ret 60x8mg | HEX | D | | | | | 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 7,23 | L/INT, KAR | | 123 | C01DX | ostatní vazodilatancia | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 13,78 | H | | | | | | | | | | | 123.2 | C01DX12 | molsidomin | parent. | 6 | MG | 105,38 | H | | 87732 | CORVATON | inj 10x1ml/2mg | HOE | D | | | | | 124 | C01EA | prostaglandiny | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3100,00 | X | | 92305 | ALPROSTAN | inf 10x0.2ml/100rg | LEX | CZ | | | | | 70426 | KARON | inj 0.2ml/100rg+sol | LEX | CZ | | | | | 61219 | PROSTIN VR | inj 1x1 ml/0.5mg | UPJ | B | | | | | 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 647,95 | X | | 91731 | PROSTAVASIN | inj sic 10x20rg | SWP | D | | | | | 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 7,28 | | | 01328 | DOPEGYT | tbl 50x250mg | EGI | H | | | | | 125.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 9,14 | | | | | | | | | | | | 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 9,14 | | | | | | | | | | | | 125.4 | C02AC05 | moxonidin do 0,2 mg v 1 tabletě včetně | p.o. | 0.3 | MG | 9,14 | | | | | | | | | | | | 1125.5 | C02AC05 | moxonidin nad 0,2 mg v 1 tabletě | p.o. | 0.3 | MG | 8,68 | | | | | | | | | | | | 125.6 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,56 | | | 02629 | CRYSTEPIN | drg 30 | LEX | CZ | | | | | 125.7 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3 | DF | 4,94 | | | | | | | | | | | | 125.8 | C02LB01 | methyldopa/hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2 | DF | 3,42 | | | | | | | | | | | | 125.9 | C02AC06 | rilmenidin | p.o. | 1 | MG | 8,68 | | | 126 | C02A | antihypertenziva působící na centrální alfa-2 receptory | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 126.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 70,09 | H | | 92074 | CATAPRESAN | inj 5x1 ml/0.15mg | BGP | D | | | | | 11823 | CATAPRESAN | inj 5x1 ml/0.15mg | BOE | D | | | | | 127 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 127.1 | C02CA | metazosin | p.o. | 20 | MG | 5,96 | | | | | | | | | | | | 127.2 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5 | MG | 12,59 | | | 94315 | DEPRAZOLIN MITE | tbl 10x1mg | LEX | CZ | | | | | 58259 | DEPRAZOLIN MITE | tbl 15x1mg | LEX | CZ | | | | | 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 3,18 | | | 88173 | DEPRAZOLIN | tbl 30x2mg | LEX | CZ | | | | | 127.4 | C02CA06 | urapidil | p.o. | 50 | MG | 6,89 | | | | | | | | | | | | 127.5 | C02CA04 | doxazosin-retardované formy do 4 mg v jedné tabletě včetně | p.o. | 4 | MG | 20,33 | L/URN | | | | | | | | | | | 127.6 | C02CA04 | doxazosin-retardované formy nad 4 mg v jedné tabletě | p.o. | 4 | MG | 11,00 | L/URN | | | | | | | | | | | 127.7 | C02CA04 | doxazosin – neretardované formy | p.o. | 4 | MG | 18,10 | L/URN | | 45214 | ZOXON 2 | tbl 30x2mg | LEX | CZ | | | | | 45215 | ZOXON 4 | tbl 30x4mg | LEX | CZ | | | | | 64799 | KAMIREN 1 | tbl 30x1mg | KRK | SLO | | | | | 64798 | KAMIREN 2 | tbl 30x2mg | KRK | SLO | | | | | 64797 | KAMIREN 4 | tbl 30x4mg | KRK | SLO | | | | | 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 221,16 | O | | 90763 | EBRANTIL I.V.25 | inj 5x5ml/25mg | BGL | D | | | | | 90765 | EBRANTIL I.V.50 | inj 5x10ml/50mg | BGL | D | | | | | 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 129.1 | C02DB01 | dihydralazin | p.o. | 75 | MG | 2,00 | | | | | | | | | | | | 129.2 | C02DB03 | endralazin | p.o. | 10 | MG | 9,43 | | | | | | | | | | | | 129.3 | C02DC01 | minoxidil | p.o. | 20 | MG | 20,14 | L/INT,KAR | | 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 283,99 | H | | | | | | | | | | | 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 30,40 | H | | 90484 | NEPRESOL | inj 5x25mg+solv. | CGC | CH | | | | | 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 273,97 | H | | 131 | C03AA | thiazidová diuretika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 131.1 | C03AA03 | hydrochlorothiazid | p.o. | 25 | MG | 0,90 | | | 00168 | HYDROCHLOROTHIAZID LECIVA | tbl 20x25mg | LEX | CZ | | | | | 132 | C03B | sulfonamidová diuretika a antihypertenziva | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 132.1 | C03BA | metipamid | p.o. | 2.5 | MG | 1,03 | | | 94810 | HYPOTYLIN | tbl 30x2.5mg | LEX | CZ | | | | | 132.2 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,59 | | | 83551 | URANDIL | tbl 30x50mg(blistr.) | LEX | CZ | | | | | 132.3 | C03BA10 | xipamid | p.o. | 20 | MG | 1,03 | | | | | | | | | | | | 132.4 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,12 | | | 96696 | INDAP | cps 30x2.5mg | PMP | CZ | | | | | 132.5 | C03B | cikletanin | p.o. | 50 | MG | 1,03 | | | | | | | | | | | | 132.6 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1,5 | MG | 1,12 | | | 133 | C03CA | kličková diuretika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,88 | | | 98219 | FURON 40MG | tbl 50x40mg | MCK | D | | | | | 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND | | | | | 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND | | | | | 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40mg | SLO | SK | | | | | 97935 | FURSEMID | tbl 100x40mg | BLU | CHO | | | | | 96328 | FURSEMID | tbl 12x40mg | BLU | CHO | | | | | 76031 | FURSEMID | tbl 48x40mg | BLU | CHO | | | | | 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,08 | | | 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | | | | | 56815 | FURORESE 500 | tbl 100x500mg | FST | D | | | | | 56814 | FURORESE 500 | tbl 50x500mg | FST | D | | | | | 56812 | FURORESE 250 | tbl 100x250mg | FST | D | | | | | 56807 | FURORESE 125 | tbl 30x125mg | FST | D | | | | | 56808 | FURORESE 125 | tbl 50x125mg | FST | D | | | | | 56809 | FURORESE 125 | tbl 100x125mg | FST | D | | | | | 56810 | FURORESE 250 | tbl 20x250mg | FST | D | | | | | 56811 | FURORESE 250 | tbl 50x250mg | FST | D | | | | | 68632 | FURORESE 500 | tbl 20x500mg | FST | D | | | | | 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,88 | | | | | | | | | | | | 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,08 | | | 134 | C03CA | kličková diuretika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 15,04 | O | | 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | BTA | SK | | | | | 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 7,36 | O | | 99333 | FUROSEMID BIOTIKA FORTE | inj 10x10ml/125mg | HBS | SK | | | | | 134.3 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15 | MG | 16,03 | O | | | | | | | | | | | 134.4 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15 | MG | 7,72 | O | | | | | | | | | | | 134.5 | C03C | kyselina etakrynová | parent. | 50 | MG | 543,63 | O | | 135 | C03D | kalium šetřící diuretika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 135.1 | C03DA01 | spironolakton | p.o. | 75 | MG | 4,84 | | | 96361 | XENALON-50 | tbl obd 20x50mg | MHA | CH | | | | | 96362 | XENALON-100 | tbl obd 20x100mg | MHA | CH | | | | | 135.2 | C03DB01 | amilorid | p.o. | 10 | MG | 1,56 | | | 87662 | AMICLARAN | tbl 50x5mg | SLO | SK | | | | | 135.3 | C03DB02 | triamteren | p.o. | 100 | MG | 1,22 | | | 136 | C03EA | kombinace thiazidových a kalium šetřících diuretik | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 136.1 | C03EA | středně silná diuretika a kalium šetřící látky | p.o. | 1 | DF | 1,17 | | | 88518 | AMICLOTON | tbl 30 | SLO | SK | | | | | 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,54 | | | 83717 | AMILORID HCT AL | tbl 50 | APA | D | | | | | 83718 | AMILORID HCT AL | tbl 100 | APA | D | | | | | 76380 | RHEFLUIN | tbl 30 | LEX | CZ | | | | | 89125 | LORADUR MITE | tbl 50x2.5mg/25mg | MCK | A | | | | | 136.3 | C03EA14 | spironolakton/butizid | p.o. | 1 | DF | 9,78 | | | 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 20,82 | O | | | | | | | | | | | 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 83,14 | O | | 00440 | DIVASCOL | inj 10x1ml/10mg | SPX | CZ | | | | | 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 138.1 | C04AC01 | kyselina nikotinová | p.o. | 0.2 | GM | 0,44 | | | | | | | | | | | | 138.2 | C04AD04 | etophyllin nikotinát | p.o. | 0.3 | GM | 1,65 | | | 00243 | OXYPHYLLIN | tbl 50x100mg | SLO | SK | | | | | 138.3 | C04AD02 | xantinol nikotinát | p.o. | 0.9 | GM | 4,57 | | | | | | | | | | | | 138.4 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 4,57 | | | | | | | | | | | | 138.5 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 7,10 | | | 66513 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 30x400mg | APA | D | | | | | 89991 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 50x400mg | APA | D | | | | | 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 100x400mg | APA | D | | | | | 54247 | APO-PENTOXIFYLLINE SR | tbl ret 100x400mg | APT | CND | | | | | 53479 | TRENTAL 400 | tbl flm 20x400mg | HBS | SK | | | | | 53480 | TRENTAL 400 | tbl flm 100x400mg | HBS | SK | | | | | 138.6 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 7,90 | | | 97702 | PENTOMER RETARD 600MG | tbl obd 20x600mg | MCK | D | | | | | 49600 | PENTOHEXAL 600 | tbl ret 30x600mg | SFS | D | | | | | 49601 | PENTOHEXAL 600 | tbl ret 50x600mg | SFS | D | | | | | 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 139.1 | C04AC | olamin nikotinát | parent. | 0.9 | GM | 20,04 | | | | | | | | | | | | 139.2 | C04AD | etophyllin/theophyllin | parent. | 0.3 | GM | 11,05 | | | 57351 | OXANTIL | inj 5x2 ml | HBS | SK | | | | | 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,25 | | | | | | | | | | | | 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 28,40 | | | 53200 | AGAPURIN | inj 5x5ml/100mg | SLO | SK | | | | | 69241 | PENTILIN 100 | inj 5x5ml/100mg | KRK | SLO | | | | | 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK | | | | | 49603 | PENTOHEXAL 300 | inf 10x15ml/300mg | PHH | D | | | | | 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 2,08 | | | | | | | | | | | | 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,50 | | | | | | | | | | | | 140.3 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2 | ML | 1,79 | | | 88088 | ERSILAN | gtt 50ml | GNO | CZ | | | | | 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 141.1 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3 | MG | 69,21 | | | 142 | C04AX | jiná periferní vasodilatancia | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 142.1 | C04AX | jiná periferní vasodilatancia | p.o. | 3 | DF | 5,72 | | | | | | | | | | | | 142.2 | C04AX02 | fenoxybenzamin | p.o. | 30 | MG | 15,54 | | | | | | | | | | | | 142.3 | C04AX19 | sulkotidil | p.o. | 0.3 | GM | 5,72 | | | | | | | | | | | | 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,72 | | | | | | | | | | | | 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,72 | | | 97026 | ENELBIN 100 RETARD | tbl ret 50x100mg | LEX | CZ | | | | | 66015 | ENELBIN 100 RETARD | tbl ret 100x100mg | LEX | CZ | | | | | 143 | C04AX | jiná periferní vasodilatancia | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 143.1 | C04AX | jiná periferní vasodilatancia | parent. | 2 | DF | 14,86 | | | | | | | | | | | | 143.2 | C04AX11 | bencyklan | parent. | 0.6 | GM | 51,52 | | | | | | | | | | | | 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 51,52 | | | 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ | | | | | 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 0,98 | | | | | | | | | | | | 144.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1 | GM | 0,81 | | | | | | | | | | | | 144.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | | | | | | | | | | | | 144.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1 | GM | 0,81 | | | | | | | | | | | | 144.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | | | | | | | | | | | | 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,81 | | | 00832 | AVIRIL H | ung 1x30gm | LEX | CZ | | | | | 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 145.1 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) | lok. | 1 | GM | 0,78 | | | | | | | | | | | | 145.2 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) | lok. | 1 | DF | 0,98 | | | | | | | | | | | | 145.3 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1 | GM | 0,78 | | | | | | | | | | | | 145.4 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1 | DF | 0,98 | | | 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použití | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 146.1 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,83 | | | 03575 | HEPAROID LECIVA | ung 1x30gm | LEX | CZ | | | | | 146.2 | C05BA03 | heparin k zevnímu použití | lok. | 1 | GM | 0,83 | | | 86042 | HEPARIN AL SALBE 30000 | ung 1x100gm | APA | D | | | | | 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D | | | | | 146.3 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1 | GM | 0,83 | | | 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 147.1 | C05CA51 | rutosidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,37 | | | 96303 | ASCORUTIN | tbl obd 50 | SLO | SK | | | | | 147.2 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 3,03 | | | 02635 | ANAVENOL | gtt 1x25ml | GNO | CZ | | | | | 147.3 | C05CA04 | troxerutin | p.o. | 0.9 | GM | 4,50 | | | | | | | | | | | | 147.4 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 6,52 | | | | | | | | | | | | 147.5 | C05CA54 | troxerutin, kombinace | p.o. | 2 | DF | 6,52 | | | 148 | C05 | jiné kapiláry stabilizující látky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 148.1 | C05BX01 | dobesilat vápenatý | p.o. | 0.75 | GM | 6,52 | | | | | | | | | | | | 148.2 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 6,52 | | | 94327 | YELLON | cps 30x20mg | SLO | SK | | | | | 148.3 | C05CX01 | tribenosid | p.o. | 0.6 | GM | 4,50 | | | 149 | C05 | jiné kapiláry stabilizující látky | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 54,26 | H | | | | | | | | | | | 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,38 | O | | 08512 | AETHOXYSKLEROL 0,5% | inj 1x30ml 0,5% | KRS | D | | | | | 08510 | AETHOXYSKLEROL 0,5% | inj 5x2ml 0.5% | KRS | D | | | | | 149.3 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1 | ML | 16,55 | O | | 20034 | AETHOXYSKLEROL 1% | inj 1x30ml 1% | KRS | D | | | | | 20033 | AETHOXYSKLEROL 1% | inj 5x2ml 1% | KRS | D | | | | | 149.4 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1 | ML | 18,43 | O | | 08511 | AETHOXYSKLEROL 2% | inj 5x2ml 2% | KRS | D | | | | | 02529 | AETHOXYSKLEROL 3% | inj 5x2ml 3% | KRS | D | | | | | 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 19,94 | O | | 90799 | AETHOXYSKLEROL 4% | inj 5x2ml 4% | KRS | D | | | | | 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | L/KAR,INT | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 150.1 | C07AA07 | Sotalol | p.o. | 0.16 | GM | 5,12 | L/KAR,INT | | 83671 | SOTAHEXAL | tbl 100x160mg | HEX | D | | | | | 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 151.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,78 | | | | | | | | | | | | 151.2 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,75 | | | 02483 | TRIMEPRANOL | tbl 50x10mg | SLO | SK | | | | | 151.3 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10 | MG | 0,29 | | | 02484 | TRIMEPRANOL | tbl 50x40mg | SLO | SK | | | | | 151.4 | C07AA02 | Oxprenolol | p.o. | 0.1 | GM | 2,74 | | | | | | | | | | | | 151.5 | C07AA03 | pindolol | p.o. | 15 | MG | 2,74 | | | | | | | | | | | | 151.6 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,74 | | | | | | | | | | | | 151.7 | C07AA12 | nadolol. | p.o. | 0.16 | GM | 2,74 | | | | | | | | | | | | 151.8 | C07AA16 | tertatolol | p.o. | 5 | MG | 2,74 | | | | | | | | | | | | 151.9 | C07AA17 | bopindolol | p.o. | 1 | MG | 4,30 | | | 96998 | SANDONORM | tbl 30x1mg | LEX | CZ | | | | | 151.10 | C07AA23 | penbutolol | p.o. | 40 | MG | 2,74 | | | | | | | | | | | | 151.11 | C07AA27 | kloranolol | p.o. | 20 | MG | 2,74 | | | 152 | C07AA | beta-blokátory, bez beta-1 selektivity | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 152.1 | C07AA | metipranolol | parent. | 10 | MG | 62,70 | O | | 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK | | | | | 152.2 | C07AA | talinolol | parent. | 50 | MG | 93,65 | O | | | | | | | | | | | 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 99,13 | O | | | | | | | | | | | 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 99,13 | O | | | | | | | | | | | 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 900,64 | O | | 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 153.1 | C07AB02 | metoprolol (do 0,05 GM včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,93 | | | 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND | | | | | 50080 | VASOCARDIN 50 | tbl 50x50mg - blistr | SLO | SK | | | | | 54150 | EGILOK 25MG | tbl 60x25mg | EGI | H | | | | | 54151 | EGILOK 50MG | tbl 60x50mg | EGI | H | | | | | 54152 | EGILOK 50MG | tbl 200x50mg | EGI | H | | | | | 153.2 | C07AB02 | metoprolol (nad 0,05 GM v jedné tabletě) | p.o. | 0.15 | GM | 2,74 | | | 45555 | BETALOC 100MG | tbl 100x100mg | APN | S | | | | | 45592 | VASOCARDIN 100 | tbl 50x100mg-blistr | SLO | SK | | | | | 59894 | EGILOK 100MG | tbl 200x100mg | EGI | H | | | | | 59893 | EGILOK 100MG | tbl 60x100mg | EGI | H | | | | | 153.3 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 3,52 | | | 46980 | BETALOC SR 200 MG | tbl ret 100x200 mg | APN | S | | | | | 46981 | BETALOC SR 200 MG | tbl ret 30x200 mg | APN | S | | | | | 153.4 | C07AB02 | metoprolol (léková forma tablet y s řízeným uvolňováním ) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 35,20 | P |

Metoprolol sukcinát v dávce do 25 mg je ordinován internistou nebo kardiologem k léčbě srdečního selhání, zejména pokročilých stadií a je určen pouze k zavedení léčby na dobu nezbytně nutnou a je možno jej předepsat maximálně v množtví 3 balení na pacienta. V indikaci léčby hypertense nelze hradit z prostředků zdravotního pojištění.

Karvediol je ordinován internistou nebo kardiologem k léčbě srdečního selhání, zejména pokročilých stadií. Karvediol v dávce 6,25 mg je určen pouze k zavedení léčby na dobu nezbytně nutnou a je možno jej předepsat maximálně v množtví 3 balení na pacienta. Cílová dávka karvediolu v této indikaci je 25-50 mg denně. V indikaci léčby hypertense nelze hradit z prostředků zdravotního pojištění.

| 155.1 | C07AG01 | labetalol | p.o. | 0.6 | GM | 19,50 | L/KAR,INT | | 87669 | TRANDATE | tbl 250x200mg | GLA | GB | | | | | 155.2 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 46,00 | P | | | | | | | | | | | 155.3 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.5 | MG | 21,00 | P | | 156 | C07AG | alfa, beta-blokátory | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 156.1 | C07AG01 | labetalol | parent. | 0.6 | GM | 1027,60 | H | | 45145 | TRANDATE | inj 5x20ml/100mg | MEH | GB | | | | | 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | | | | | | 157.1 | C07CB03 | atenolol a jiná diuretika | p.o. | 1 | DF | 4,34 | | | 76715 | TENORETIC | tbl obd 28 | ZNC | GB | | | | | 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,34 | | | | | | | | | | | | 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertens. | p.o. | 0.5 | DF | 0,73 | | | 76981 | TRIMECRYTON | tbl 30(blistr) | LEX | CZ | | | | | 157.4 | C07BB07 | bisoprolol a thiazidy | p.o. | 1 | DF | 3,71 | | | 158 | C08CA | antagonisté vápníku dihydropyridinové řady | p.o. | | | | | | 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 7,22 | | | | | | | | | | | | 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 5,53 | | | | | | | | | | | | 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 5,28 | | | | | | | | | | | | 158.4 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5 | MG | 5,53 | | | | | | | | | | | | 158.5 | C08CA05 | nifedipin | p.o. | 30 | MG | 1,56 | | | | | | | | | | | | 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,10 | | | 91692 | NIFECARD RETARD | tbl ret 30x20mg | LEK | SLO | | | | | 65381 | NIFEHEXAL 20 RETARD | tbl obd 50x20mg | HEX | D | | | | | 65382 | NIFEHEXAL 20 RETARD | tbl obd 100x20mg | HEX | D | | | | | 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO | | | | | 158.7 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,37 | | | 65383 | NIFEHEXAL 40 RETARD | tbl obd 30x40mg | HEX | D | | | | | 65384 | NIFEHEXAL 40 RETARD | tbl obd 50x40mg | HEX | D | | | | | 65385 | NIFEHEXAL 40 RETARD | tbl obd 100x40mg | HEX | D | | | | | 158.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1 | DF | 5,77 | | | 03033 | CORDIPIN XL | tbl ret 30x40mg | KRK | SLO | | | | | 55910 | CORDIPIN XL | tbl ret 20x40mg | KRK | SLO | | | | | 158.9 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 136,08 | X | | 94189 | DILCEREN | tbl obd 50x30mg | SLO | SK | | | | | 158.10 | C08CA07 | nisoldipin | p.o. | 20 | MG | 5,53 | | | | | | | | | | | | 158.11 | C08CA08 | nitrendipin | p.o. | 20 | MG | 5,53 | | | 69305 | UNIPRES 10 | tbl 20x10mg | KRK | SLO | | | | | 03079 | UNIPRES 10 | tbl 30x10mg | KRK | SLO | | | | | 03078 | UNIPRES 20 | tbl 30x20mg | KRK | SLO | | | | | 69306 | UNIPRES 20 | tbl 20x20mg | KRK | SLO | | | | | 83082 | LUSOPRESS | tbl 28x20mg | LUS | I | | | | | 158.12 | C08CA09 | lacidipin | p.o. | 4 | MG | 7,22 | | | 59912 | LACIPIL 4MG | tbl obd 28x4mg | GLA | E | | | | | 158.13 | C08CA10 | nilvadipin | p.o. | 8 | MG | 6,50 | | | | | | | | | | | | 158.14 | C08CX01 | mibefradil | p.o. | 50 | MG | 13,20 | L/INT,KAR | | 159 | C08CA | antagonisté vápníku dihydropyridinové řady | parent. | H | | | | | 159.1 | C08CA03 | isradipin | parent. | 5 | MG | 3074,59 | H | | | | | | | | | | | 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3074,59 | H | | | | | | | | | | | 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3438,25 | X | | 88858 | NIMOTOP S | inf 1x50ml/10mg | BAY | D | | | | | 94535 | NIMOTOP S | inf 5x50ml/10mg | BAY | D | | | | | 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 160.1 | C08DA01 | verapamil neretardované lékové formy do 240 mg v jedné tabletě včetně | p.o. | 0.24 | GM | 5,00 | | | 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D | | | | | 56153 | VERAHEXAL 40 | tbl obd 50x40mg | FST | D | | | | | 56154 | VERAHEXAL 40 | tbl obd 100x40mg | FST | D | | | | | 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D | | | | | 56156 | VERAHEXAL 80 | tbl obd 50x80mg | FST | D | | | | | 56157 | VERAHEXAL 80 | tbl obd 100x80mg | FST | D | | | | | 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D | | | | | 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D | | | | | 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D | | | | | 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D | | | | | 77035 | VERAPAMIL AL 40 | tbl obd 100x40mg | APA | D | | | | | 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D | | | | | 77037 | VERAPAMIL AL 80 | tbl obd 100x80mg | APA | D | | | | | 86045 | VERAPAMIL AL 120 | tbl obd 50x120mg | APA | D | | | | | 86046 | VERAPAMIL AL 120 | tbl obd 100x120mg | APA | D | | | | | 99305 | VERAPAMIL 40-SLOVAKOFARMA | tbl obd 30x40mg | SLO | SK | | | | | 99306 | VERAPAMIL 80-SLOVAKOFARMA | tbl obd 30x80mg | SLO | SK | | | | | 160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 5,77 | | | 43877 | VEROGALID ER 240MG | tbl ret 30x240mg | GNO | CZ | | | | | 43879 | VEROGALID ER 240MG | tbl ret 100x240mg | GNO | CZ | | | | | 56164 | VERAHEXAL RR | tbl ret 30x240mg | FST | D | | | | | 56165 | VERAHEXAL RR | tbl ret 50x240mg | FST | D | | | | | 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D | | | | | 93679 | LEKOPTIN RETARD | tbl obd 20x240mg | LEK | SLO | | | | | 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,00 | | | 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 360,71 | H | | 09210 | LEKOPTIN | inj 50x2ml/5mg | LEK | SLO | | | | | 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,28 | | | 93186 | BLOCALCIN | tbl 50x60mg | LCM | CZ | | | | | 94321 | BLOCALCIN 90 RETARD | tbl ret 30x90mg | LCM | CZ | | | | | 94314 | DIACORDIN 60 | tbl 50x60mg | LEX | CZ | | | | | 93711 | DIACORDIN 90 RETARD | tbl 30x90mg | LEX | CZ | | | | | 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,77 | | | 76736 | DIACORDIN 120 RETARD | tbl ret 30x120mg | LEX | CZ | | | | | 58752 | DIACORDIN 240 SR | cps ret 30x240mg | LEX | CZ | | | | | 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 163.1 | C08DB01 | diltiazem | parent. | 25 | MG | 319,18 | H | | 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 164.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,52 | | | 31385 | TENSIOMIN 12.5MG | tbl 30x12.5mg | EGI | H | | | | | 47282 | TENSIOMIN 12.5MG | tbl 200x12.5mg | EGI | H | | | | | 49564 | TENSIOMIN 12.5MG | tbl 90x12.5mg | EGI | H | | | | | 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS | | | | | 96903 | APO-CAPTO | tbl 100x12.5mg | APT | CND | | | | | 164.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,25 | | | 31215 | TENSIOMIN 25MG | tbl 30x25mg | EGI | H | | | | | 47283 | TENSIOMIN 25MG | tbl 200x25mg | EGI | H | | | | | 49562 | TENSIOMIN 25MG | tbl 90x25mg | EGI | H | | | | | 68839 | APO-CAPTO 25MG | tbl 100x25mg | APT | CND | | | | | 90975 | KATOPIL | tbl 40x25mg | GLN | YU | | | | | 59379 | CAPTOPRIL 25 SVUS | tbl 30x25mg | SVS | CZ | | | | | 59380 | CAPTOPRIL 25 SVUS | tbl 50x25mg | SVS | CZ | | | | | 59381 | CAPTOPRIL 25 SVUS | tbl 100x25mg | SVS | CZ | | | | | 164.3 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 4,00 | | | 31216 | TENSIOMIN 50MG | tbl 20x50mg | EGI | H | | | | | 47284 | TENSIOMIN 50MG | tbl 200x50mg | EGI | H | | | | | 49563 | TENSIOMIN 50MG | tbl 90x50mg | EGI | H | | | | | 90976 | KATOPIL | tbl 40x50mg | GLN | YU | | | | | 164.4 | C09AA02 | enalapril hydrogenmaleát (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 5,62 | | | 45273 | ENAP 5 MG | tbl 30x5 mg | KRK | SLO | | | | | 55637 | ENALAPRIL LACHEMA 5 | tbl 100x5 mg | LCM | CZ | | | | | 59916 | ENALAPRIL LACHEMA 5 | tbl 60x5 mg | LCM | CZ | | | | | 85927 | ENALAPRIL LACHEMA 5 | tbl 20x5 mg | LCM | CZ | | | | | 83508 | EDNYT 5 MG | tbl 100x5 mg | GED | H | | | | | 83503 | APO-ENALAPRIL 5 MG | tbl 100x5 mg | APQ | MEX | | | | | 83505 | EDNYT 2.5MG | tbl 28x2.5mg | GED | H | | | | | 83507 | EDNYT 5MG | tbl 28x5mg | GED | H | | | | | 84514 | ACETENSIL 5MG | tbl 10x5mg | ANO | E | | | | | 84515 | ACETENSIL 5MG | tbl 60x5mg | ANO | E | | | | | 164.5 | C09AA02 | enalapril hydrogenmaleát (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 4,32 | | | 83510 | EDNYT 10 MG | tbl 100x 10 mg | GED | H | | | | | 55638 | ENALAPRIL LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | | | 59917 | ENALAPRIL LACHEMA 10 | tbl 60x10mg | LCM | CZ | | | | | 83509 | EDNYT 10MG | tbl 28x10mg | GED | H | | | | | 92576 | ENALAPRIL LACHEMA 10 | tbl 20x10mg | LCM | CZ | | | | | 59642 | ENAP 10MG | tbl 100x10mg | KRK | SLO | | | | | 45274 | ENAP 10MG | tbl 30x10mg | KRK | SLO | | | | | 64839 | APO-ENALAPRIL 10MG | tbl 100x10mg | APQ | MEX | | | | | 164.6 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10 | MG | 3,40 | | | 55639 | ENALAPRIL LACHEMA 20 | tbl 100x20mg | LCM | CZ | | | | | 84516 | ACETENSIL 20MG | tbl 28x20mg | ANO | E | | | | | 85928 | ENALAPRIL LACHEMA 20 | tbl 20x20mg | LCM | CZ | | | | | 83511 | EDNYT 20MG | tbl 28x20mg | GED | H | | | | | 45275 | ENAP 20MG | tbl 30x20mg | KRK | SLO | | | | | 59641 | ENAP 20MG | tbl 100x20 | KRK | SLO | | | | | 64840 | APO-ENALAPRIL 20MG | tbl 100x20mg | APQ | MEX | | | | | 164.7 | C09AA03 | lisinopril | p.o. | 10 | MG | 6,26 | | | 67561 | DAPRIL 5 | tbl 30x5mg | MOE | CY | | | | | 67562 | DAPRIL 10 | tbl 30x10mg | MOE | CY | | | | | 67563 | DAPRIL 20 | tbl 20x20mg | MOE | CY | | | | | 164.8 | C09AA04 | perindopril | p.o. | 4 | MG | 7,25 | | | | | | | | | | | | 164.9 | C09AA05 | ramipril | p.o. | 2.5 | MG | 7,25 | | | 56978 | TRITACE 2.5 | tbl 50x2.5mg | HBS | SK | | | | | 56982 | TRITACE 5 | tbl 50x5mg | HBS | SK | | | | | 56974 | TRITACE 1.25 | tbl 50x1.25mg | HBS | SK | | | | | 56973 | TRITACE 1.25 | tbl 30x1.25mg | HBS | SK | | | | | 56981 | TRITACE 5 | tbl 30x5mg | HBS | SK | | | | | 56977 | TRITACE 2.5 | tbl 30x2.5mg | HBS | SK | | | | | 164.10 | C09AA06 | quinapril | p.o. | 15 | MG | 7,25 | | | | | | | | | | | | 164.11 | C09AA07 | benazepril | p.o. | 7.5 | MG | 7,25 | | | | | | | | | | | | 164.12 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 7,25 | | | | | | | | | | | | 164.13 | C09AA09 | fosinopril | p.o. | 1 | DF | 7,25 | | | | | | | | | | | | 164.14 | C09AA10 | trandolapril | p.o. | 2 | MG | 7,25 | | | | | | | | | | | | 164.15 | C09AA11 | spirapril | p.o. | 6 | MG | 7,25 | | | | | | | | | | | | 164.16 | C09AA12 | delapril | p.o. | 30 | MG | 7,25 | | | | | | | | | | | | 164.17 | C09AA13 | moexipril | p.o. | 15 | MG | 7,25 | | | 165 | C09AA | inhibitory angiotenzin konvertujícího enzymu | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 165.1 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 27,76 | H | | 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO | | | | | 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 4,78 | | | 53242 | CAPTOHEXAL COMP.25/25 | tbl 20x25mg/25mg | SFS | D | | | | | 53243 | CAPTOHEXAL COMP.25/25 | tbl 50x25mg/25mg | SFS | D | | | | | 53245 | CAPTOHEXAL COMP.25/25 | tbl 100x25mg/25mg | SFS | D | | | | | 53246 | CAPTOHEXAL COMP.50/25 | tbl 20x50mg/25mg | SFS | D | | | | | 53248 | CAPTOHEXAL COMP.50/25 | tbl 50x50mg/25mg | SFS | D | | | | | 53249 | CAPTOHEXAL COMP.50/25 | tbl 100x50mg/25mg | SFS | D | | | | | 53250 | CAPTOHEXAL COMP.25/12.5 | tbl 20x25mg/12.5mg | SFS | D | | | | | 53251 | CAPTOHEXAL COMP.25/12.5 | tbl 50x25mg/12.5mg | SFS | D | | | | | 53252 | CAPTOHEXAL COMP.25/12.5 | tbl 100x25mg/12.5mg | SFS | D | | | | | 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 5,22 | | | 55429 | ENAP-HL | tbl 30 | KRK | SLO | | | | | 66506 | ENAP-H | tbl 30 | KRK | SLO | | | | | 166.3 | C09BA06 | quinapril a diuretika | p.o. | 1 | DF | 5,28 | | | | | | | | | | | | 166.4 | C09BA07 | benazepril a diuretika | p.o. | 1 | DF | 5,06 | | | | | | | | | | | | 166.5 | C09BB05 | felodipin a ramipril | p.o. | 1 | DF | 10,50 | | | | | | | | | | | | 166.6 | C09BB10 | trandolapril/verapamil | p.o. | 1 | DF | 11,10 | | | 167 | C09CA | antagonisté angiotensinu II | p.o. | Z | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 167.1 | C09CA01 | losartan | p.o. | 50 | MG | 22,00 | Z | | | | | | | | | | | 167.2 | C09CA02 | eprosartan | p.o. | 600 | MG | 22,00 | Z | | | | | | | | | | | 167.3 | C09CA03 | valsartan | p.o. | 80 | MG | 22,00 | Z | | 56240 | DIOVAN 160 | cps 28x160mg | NPA | CH | | | | | 167.4 | C09CA04 | irbesartan | p.o. | 150 | MG | 22,00 | Z | | 53657 | APROVEL 300MG | tbl 28x300mg | SWI | F | | | | | 167.5 | C09CA06 | kandesartan | p.o. | 8 | MG | 22,00 | Z | | 53389 | ATACAND 16 MG | tbl 28x16mg | APN | S | | | | | 167.6 | C09CA07 | telmisartan | p.o. | 40 | MG | 22,00 | Z | | 64087 | PRITOR 80 | tbl 28x80 | GXW | I | | | | | 64801 | PRITOR 40MG | tbl 28x40mg | GXW | I | | | | | 167.7 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 22,40 | Z | | | | | | | | | | | 167.8 | C09DA06 | kandesartan v kombinaci s thiazidy | p.o. | 1 | DF | 22,40 | Z | | 168 | C10AA | hypolipidemika ze skupiny statinů | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Simvastatin, lovastatin: léčba nemocných s manifestní aterosklerózou (sekundární prevence) s izolovanou hypercholesterolémií nebo se smíšenou hyperlipidémií s převahou hypercholesterolémie, možno předepsat vždy jen jedno hypolipidemikum (nelze kombinovat statiny a fibráty)

Léčbu atorvastatinem, cerivastatinem, fluvastatinem a pravastatinem ordinuje kardiolog, internista, diabetolog nebo lékař pracující v poradnách pro poruchy metabolizmu lipidů:

• a) léčba nemocných s familiární hypercholesterolémií

• b) léčba nemocných s manifestní aterosklerózou (sekundární prevence) s izolovanou hypercholesterolémií nebo s kombinovanou hyperlipidémií s převahou hypercholesterolémie

• c) léčba nemocných s kumulací rizikových faktorů (s vysokým rizikem kardiovaskulární příhody vyjádřeným absolutním desetiletým rizikem 10% a více ) s izolovanou hypercholesterolémií či s kombinovanou hyperlipidémií s převahou hypercholesterolémie

| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P | | 59727 | SIMGAL 10MG | tbl obd 28x10mg | GNO | CZ | | | | | 66024 | SIMVOR 10MG | tbl obd 30x10mg | RXY | IND | | | | | 58136 | VASILIP 10 | tbl obd 28x10mg | KRK | SLO | | | | | 168.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P | | 66026 | SIMVOR 20MG | tbl obd 30x20mg | RXY | IND | | | | | 59728 | SIMGAL 20MG | tbl obd 28x20mg | GNO | CZ | | | | | 58064 | VASILIP 20 | tbl obd 28x20mg | KRK | SLO | | | | | 168.3 | C10AA01 | simvastatin (nad 20 mg v jedné tabletě) | p.o. | 1 | DF | 32,56 | P | | 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND | | | | | 59729 | SIMGAL 40MG | tbl obd 28x40mg | GNO | CZ | | | | | 168.4 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P | | 01300 | APO-LOVASTATIN 20 | tbl 30x20mg | APT | CND | | | | | 53286 | APO-LOVASTATIN 20 | tbl 100x20mg | APT | CND | | | | | 45184 | HOLETAR | tbl 20x20mg | KRK | SLO | | | | | 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO | | | | | 53506 | MEDOSTATIN 20MG | tbl 30x20mg | MOE | CY | | | | | 53507 | MEDOSTATIN 20MG | tbl 100x20mg | MOE | CY | | | | | 59800 | LOVACARD 20 | tbl 28x20mg | LEX | CZ | | | | | 168.5 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P | | 59799 | LOVACARD 40 | tbl 28x40mg | LEX | CZ | | | | | 01254 | APO-LOVASTATIN 40 | tbl 30x40mg | APT | CND | | | | | 53287 | APO-LOVASTATIN 40 | tbl 100x40mg | APT | CND | | | | | 168.6 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P | | | | | | | | | | | 168.7 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P | | | | | | | | | | | 168.8 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě ) | p.o. | 1 | DF | 25,90 | P | | | | | | | | | | | 168.9 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,50 | P | | | | | | | | | | | 168.10 | C10AA04 | fluvastatin (nad 20 mg do 40 MGv jedné tabletě včetně) | p.o. | 1 | DF | 18,50 | P | | | | | | | | | | | 168.11 | C10AA04 | fluvastatin (nad 40 MGv jedné tabletě ) | p.o. | 1 | DF | 25,90 | P | | | | | | | | | | | 168.12 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 25,90 | P | | | | | | | | | | | 168.13 | C10AA05 | atorvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1 | DF | 42,73 | P | | | | | | | | | | | 168.14 | C10AA05 | atorvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1 | DF | 70,50 | P | | | | | | | | | | | 168.15 | C10AA06 | cerivastatin (do 0,10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 10,50 | P | | | | | | | | | | | 168.16 | C10AA06 | cerivastatin (nad 0,10 do 0,20 MG včetně v jedné tabletě) | p.o. | 1 | DF | 19,55 | P | | | | | | | | | | | 168.17 | C10AA06 | cerivastatin (nad 0,20 MG v jedné tabletědo 0,30 MG v jedné tabletě včetně) | p.o. | 1 | DF | 25,90 | P | | | | | | | | | | | 168.18 | C10AA06 | cerivastatin ( nad 0,30 MG v jedné tabletě ) | p.o. | 1 | DF | 31,60 | P | | 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 169.1 | C10AB | etofylin klofibrát | p.o. | 0.5 | GM | 4,79 | | | 49609 | DUOLIP FORTE | tbl 100x500mg | MCK | A | | | | | 49608 | DUOLIP FORTE | tbl 30x500mg | MCK | A | | | | | 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 8,50 | | | 21569 | REGADRIN B | drg 50x200mg | BCE | D | | | | | 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 8,50 | | | 53941 | INNOGEM 300MG | cps 100x300mg | EGI | H | | | | | 96574 | GEVILON | tbl obd 30x450mg | LEX | CZ | | | | | 44651 | APO-GEMFIBROZIL 600 | tbl obd 100x600mg | APT | CND | | | | | 76222 | IPOLIPID | cps 250 | MOE | CY | | | | | 76224 | IPOLIPID | cps 1000 | MOE | CY | | | | | 76223 | IPOLIPID | cps 500 | MOE | CY | | | | | 67026 | IPOLIPID | cps 50 | MOE | CY | | | | | 76221 | IPOLIPID | cps 100 | MOE | CY | | | | | 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 8,41 | | | 85813 | LIPANTHYL | cps 50x100mg | FFR | F | | | | | 97669 | LIPANTHYL 100 | cps 50x100mg | LCM | CZ | | | | | 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1 | DF | 10,50 | | | 45295 | FENOFIBRATE PHARMAVIT SR 250MG | cps 30x250mg | ETP | F | | | | | 45296 | FENOFIBRATE PHARMAVIT SR 250MG | cps 30x250mg | PLF | H | | | | | 76502 | LIPANTHYL 200 M | cps 30x200mg | FFR | F | | | | | 92327 | LIPANTHYL 200 M | cps 30x200mg | LCM | CZ | | | | | 169.6 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 8,50 | | | | | | | | | | | | 169.7 | C10AD06 | acipimox | p.o. | 500 | MG | 11,73 | | | 170 | C10AC | hypolipidemika ze skupiny pryskyřic | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje kardiolog, internista nebo lékař pracující v poradnách pro léčbu poruch metabolismu lipidů:

• a) léčba pacientů s hyperlipoproteinemií s vysokou hladinou cholesterolu,

• b) léčba pacientů s pruritem při biliární cirhóze.

| 170.1 | C10AC01 | cholestyramin | p.o. | 14 | GM | 31,09 | P | | 94031 | VASOSAN P | plv 1x400gm | FOP | D | | | | | 94033 | VASOSAN S | plv 1x400gm | FOP | D | | | | | 170.2 | C10AC02 | colestipol | p.o. | 20 | GM | 59,39 | P | | 94764 | COLESTID | plv 50x5gm | UPJ | B | | | | | 171 | D01AA | antimykotika pro lokální podání ze skupiny antibiotik | lok. | | | | | | 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 2,54 | | | 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | CZ | | | | | 171.2 | D01AA02 | natamycin | lok. | 1 | GM | 1,96 | | | 172 | D01AC | antimykotika pro lokální podání ze skupiny derivátu imidazolu | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 172.1 | D01AC01 | klotrimazol do 20 g včetně | lok. | 1 | GM | 1,96 | | | 86262 | CANESTEN | crm 1x20gm | LEX | CZ | | | | | 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D | | | | | 93483 | CLOTRIMAZOLUM POLFA | crm 20gm 1% | POL | PL | | | | | 172.2 | D01AC01 | klotrimazol nad 20 g | lok. | 1 | GM | 1,65 | | | | | | | | | | | | 172.3 | D01AC02 | mikonazol | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.4 | D01AC03 | ekonazol lékové formy krému | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.5 | D01AC03 | ekonazol (lékové formy tekuté, lipogelu a pasty) | lok. | 1 | GM | 3,52 | | | | | | | | | | | | 172.6 | D01AC05 | isokonazol | lok. | 1 | ML | 1,96 | | | | | | | | | | | | 172.7 | D01AC08 | ketokonazol | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.8 | D01AC10 | bifonazol | lok. | 1 | GM | 2,49 | | | | | | | | | | | | 172.9 | D01AC11 | oxikonazol | lok. | 1 | GM | 2,49 | | | 99248 | MYFUNGAR | crm 1x30gm | LEX | CZ | | | | | 172.10 | D01AC12 | fenticonazol | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.11 | D01AC16 | flutrimazol | lok. | 1 | GM | 5,88 | | | 53457 | MICETAL | crm 1x15gm 1% | MCI | CZ | | | | | 53905 | MICETAL | spr 1x30ml 1% | MCI | CZ | | | | | 172.12 | D01AC20 | kombinace | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.13 | D01AC51 | clotrimazol/urea | lok. | 1 | GM | 1,96 | | | | | | | | | | | | 172.14 | D01AC60 | bifonazol, kombinace | lok. | 1 | GM | 29,33 | P |

Léčbu ordinuje dermatolog u onychomykóz, doložených kultivačním vyšetřením a dokladovanou kontraindikací k použití systémové antimykotické terapie.

Léčbu terbinafinem ordinuje dermatolog:

• a) těžké formy dermatomykóz vyvonalých dermatofyty na základě kultivačního nebo mikroskopického vyšetření

• b) těžké formy nehtových mykóz, platí-li alespoň jedna z následujících podmínek:

• postižení celé nehtové ploténky

• postižení minimálně čtyř nehtových plotének tak, že každá z nich má postižení zasahující více než 30% za volný okraj nehtu proximálním směrem

• postižení nehtu palce dolní končetiny

Podmínkou zahájení léčby ad b) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.

Léčbu ordinuje chirurg, ortoped, gynekolog, otorhinolaryngolog nebo dermatolog:

• a) léčba bércových vředů,

• b) léčba nekrotických poúrazových nebo pooperačních ran,

• c) ošetřování nekrotických ran a dekubitů.

Léčbu deriváty vitaminu D v lokálních lékových formách ordinuje dermatolog:

• a) léčba torpidních lokalizovaných forem psoriázy nereagující na standardní léčbu v množství maximálně 100 g týdně.

• b) v ostatních případech pouze po schválení revizním lékařem zdravotní pojišťovny.

Léčbu ordinuje dermatolog:

• a) léčba těžkých generalizovaných forem psoriázy nereagujících na jinou léčbu,

• b) ostatní těžké formy poruchy keratinizace nereagující na jinou léčbu pouze po předchozím schválení revizním lékařem

• c) kožní T-lymfomy